Doctors really should take into consideration no matter whether their patients with fundamental NAION chance aspects can be adversely affected by use of PDE5 inhibitors. People who have by now knowledgeable NAION are at enhanced threat of NAION recurrence. Consequently, PDE5 inhibitors, such as LEVITRA, needs to be employed with warning in these in